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Ultramarathon running represents a major physical challenge even for elite athletes.
Runners wellbeing may be challenged by fluid and electrolyte disturbances, hemolysis
and skeletal muscle damage, decline in hepatic function and kidney injury. We
hypothesized that these effects may even be exacerbated in non-elite runners.
Physiological, hematological and biochemical parameters of ten males (26–45 years,
weekly training time 8.5 h), participating in a mountain ultramarathon (67 km;
approximately 4,500 m of total ascent), were determined before (PRE), immediately
after finishing the ultramarathon (POST), and 24 h after the individual finish (REC).
Race times of the 8 finishers (2 drop-outs due to hot ambient temperature) varied
between 10.4 and 16.1 h, which almost represents the range of the entire starter field
(8.82 h–17.47 h). The following changes in mean values of selected markers for skeletal
muscle damage and kidney injury were observed from PRE to POST: creatine kinase
(CK) + 1289%, lactate dehydrogenase (LDH) + 87%, serum creatinine (CR) + 72%,
blood urea nitrogen (BUN)+ 96%, and estimated glomerular filtration rate (eGFR) – 45%.
Values of CK+ 1447%, LDH+ 56%, and BUN+ 71% remained elevated at REC. White
blood cells were increased (+ 137%) only POST. In conclusion, CK and LDH levels and
leucocytosis may be considered to be relatively harmless “side-effects” of prolonged
running in this group of male subjects with rather moderate ultramarathon experience
and training status. However, acute kidney injury may become clinically relevant in this
population under the certain conditions, which should be considered by responsible
race managers and medical advisors.
Keywords: ultramarathon running, health effects, immune system, acute kidney injury, muscle damage
Abbreviations: BG, blood glucose; BUN, blood urea nitrogen; Ca, calcium; CK, creatine kinase; CL, chloride; CR, creatinine;
GFR, glomerular filtration rate; Hct, haematocrit; K, potassium; LDH, lactate dehydrogenase; LYM, lymphocytes; MG,
magnesium; MONO, monocytes; NA, sodium; NEU, neutrophils; PLT, platelets; RBC, red blood cells; WBC, white blood
cells.
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INTRODUCTION
Long-distance endurance competitions, particularly
ultramarathon runs, are challenging events, potentially affecting
various physiological functions (Knechtle and Nikolaidis, 2018).
Many studies have analyzed physiological and pathophysiological
responses to rather moderate running distances such as half-
marathons (21.1 km) or traditional marathons (42.2 km)
(Tian et al., 2011; Traiperm et al., 2013; Shin et al., 2016). In
contrast, ultramarathons (distances > 42.2 km including a high
variety of different course profiles) have been rarely studied.
However, they represent an outstanding opportunity to evaluate
adaptive responses to extreme loads and stress (Millet and
Millet, 2010; Eichenberger et al., 2012). Differences in distance
covered and running intensity of various competitions (half-
marathons, marathons, and ultramarathons) may differently
affect physiological responses and trigger different pathological
events in adult non-elite runners (Jastrzębski et al., 2016;
Shin et al., 2016).
For instance, fluid and electrolyte disturbances, hemolysis and
skeletal muscle damage can occur during long-distance running
(Knechtle and Nikolaidis, 2018). Body mass (BM) reduction
due to fluid loss is a common observation after ultramarathon
running (Kao et al., 2008; Knechtle and Nikolaidis, 2018). A slight
reduction (≤ 2%) is usually not associated with impaired running
performance and/or significant fluid and electrolyte disturbances
(Cheuvront et al., 2007; Hou et al., 2015). In contrast, BM
loss in excess of 2% may negatively affect exercise performance
(Casa et al., 2005; Cheuvront et al., 2007; Sawka et al., 2007;
Stearns et al., 2009). Loss of BM is determined by the sweating
rate and fluid consumption during the competition but can
also be caused by loss of solid body mass (skeletal muscle
mass, fat mass) (Knechtle et al., 2012). The amount of fluid
loss due to sweating in marathon running is highly variable
and can exceed 2.8 L/h (Costill, 1977). The average loss of
sweat during marathon running was reported to range from
0.83 L/h (< 15◦C ambient temperature) to 1.2 L/h (warm
weather, > 15◦C), primarily depending on the duration and
intensity of exercise and the ambient temperature (Cheuvront
and Haymes, 2001). Sodium sweat concentration is variable as
well and is determined by sweat rate, heat acclimation and
hydration, averaging ∼50 mmol/L (range: 10–100 mmol/L)
(Allan and Wilson, 1971; Sawka et al., 2007). Compared to blood
reference range (136–145 mmol/L) sweat is hypotonic (Kratz
et al., 2004), but can trigger electrolyte disturbances when sweat
loss cannot be compensated by adequate fluid ingestion. Thus,
not replacing sweat-induced fluid loss will cause hypernatremia
and drinking solely water will provoke hyponatremia, which is
frequently observed in ultramarathon running (Meinders and
Meinders, 2007; Sawka et al., 2007; Hoffman et al., 2012; Krabak
et al., 2014, 2017). Both types of electrolyte disturbances may have
either relatively harmless or even severe health consequences
such as headache, nausea, and vomiting, or even seizures, cerebral
and pulmonary edema or death (Ayus et al., 2000; Hsieh et al.,
2002; Krabak et al., 2014, 2017).
Hemolysis due to repetitive foot strikes and/or gastrointestinal
bleeding may cause runner’s anemia (Kratz et al., 2006; Ottomano
and Franchini, 2012; Traiperm et al., 2013) and microtrauma
in skeletal muscle may even trigger rhabdomyolysis, indicated
by increases in plasma creatine kinase (CK) and lactate
dehydrogenase (LDH) levels after marathon running (Kobayashi
et al., 2005; Tian et al., 2011). Muscle damage induces systemic
inflammation (e.g., indicated by elevated IL-6 levels) and activates
the immune system, e.g., indicated by elevated white blood cell
count (leucocytosis) (Suzuki et al., 2003; Kasprowicz et al., 2013;
Traiperm et al., 2013). Markers of impaired kidney function
or kidney injury [e.g., creatinine (CR), blood urea nitrogen
(BUN), glomerular filtration rate (GFR)] support the occurrence
of rhabdomyolysis to clinical relevant levels in up to 40% of
marathon finishers (McCullough et al., 2011; Shin et al., 2016;
Traiperm et al., 2016).
How ultramarathon running can affect these parameters,
especially in non-elite runners, has been less investigated. The
severity of skeletal muscle damage, liver and kidney function,
seem to be directly related to the distance covered, e.g., 42.2 vs.
100 vs. 308 km (Wu et al., 2004; Kim et al., 2007; Shin et al., 2016).
However, severe muscular damage has not been demonstrated in
every study (Lippi et al., 2012; Bird et al., 2014; Shin et al., 2016;
Belli et al., 2018). Also, sports anemia and hyponatremia seem to
occur slightly more frequently after completing ultramarathons
compared to shorter distances (Knechtle et al., 2011; Lippi et al.,
2012; Scotney and Reid, 2015; Cairns and Hew-Butler, 2016;
Jastrzębski et al., 2016). Despite time of workload as widely
accepted parameter affecting levels of serum enzymes (primarily
known for muscle and liver damage markers), it has become
evident that age, total muscle mass, climate conditions and type of
workload (eccentric workload as during downhill running) and
level of experience are also key factors in determining systemic
changes to acute stress induced by prolonged running (Kim et al.,
2009; Malm et al., 2004; Hou et al., 2015; Jastrzębski et al., 2015,
2016). For instance, higher age, increased exercise intensity and
eccentric workload were shown to aggravate liver and muscle
damage after ultramarathon running, whereas white blood cells
and serum electrolyte concentration and metabolic consequences
were found to change similarly in all ages and training groups
(Jastrzębski et al., 2015, 2016).
The individual systemic changes following ultramarathon
running are dependent on various parameters. However,
only very few data are available on physiological responses
and/or adverse health effects in adult non-elite ultramarathon
runners. Thus, the aim of the present study was to investigate
physiological and pathophysiological responses in adult non-
elite ultramarathon participants. We hypothesized that a large
proportion of these individuals would report clinically relevant
levels of markers of skeletal muscle damage, inflammation, fluid
and electrolyte disturbances and impairment of kidney function.
MATERIALS AND METHODS
Study Participants
All local runners in the age group from 20 to 50 were selected
from the entry list of male starters. Since measurements were
performed on 3 consecutive days, it was only feasible for locals
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to participate in the present study. The 32 starters available
were contacted 4 weeks prior to the event. They were informed
about the procedure of measurements and asked to fill a
questionnaire on anthropometric data, training and medical
history, and smoking behavior. Exclusion criteria were any
disease associated with an increased risk due to the ultramarathon
running event (assessed by an experienced physician), and very
high training volumes (a recreational athlete was here defined
as a person training < 15 h/week) with the intention to recruit
only recreational participants. Ten athletes (training volume: 4–
15 h, median: 8.5 h) fulfilled all inclusion criteria and were
included after providing written informed consent. The study
was approved by the local ethics review board (University of
Innsbruck, Institute of Sport Science).
Competition Profile and Determination of
Race Time
The competition was performed as a non-stop mountain
ultramarathon (67 km distance and approximately 4,500 m of
total ascent and descent, and the highest point of the course was
1590 m a.s.l), taking place annually in Gmunden, Upper Austria
(Figure 1). Race participants could choose their starting time
individually between 3:00 and 5:00 am; cut off for finishing the
race was set at 9:00 pm at the same day. Food and beverages
(water, soft drinks and sports drinks, soups, fruits, sweets,
energy bars) were provided by the organizers at specific stations
approximately every 5 km along the race course. 210 starters were
men and only 19 women, and the drop-out rate was 26% in men
and 21% in women.
Participants were wearing a heart rate monitor during
competition with a recording interval of one second (Suunto
Ambit 3; Suunto, Vantaa, Finland) to monitor race times,
and average and maximal heart rates during the race (Suunto
Movescount). Race time and average running speed were
calculated using exact start and finishing times. We were not able
to monitor food and fluid intake throughout the competition due
to the wide spread of refreshment stations throughout the course.
Competitors were asked POST to estimate their liquid intake.
Blood sampling was performed by the same physician on the
day before the competition (PRE), within 10 min after finishing
the race (POST) and 24 h after the individual finish (REC).
Body height and resting heart rate measurements were performed
PRE, body mass was determined PRE and POST. Blood lactate
concentrations were only determined POST. See Figure 2 for the
timeline for all measurements.
Blood Analyses: Red and White Blood
Cell Count, Electrolyte Concentration
and Markers for Muscle and Kidney
Injury
Whole blood was taken from the median cubital vein using
different blood collection tubes (∼9 mL K3 EDTA, 3 mL Lithium
Heparin, 3 mL clot activator for serum analysis; BD Vacutainer,
BD diagnostics, New Jersey, United States). The tubes were
stored at 4◦C and transported to the local hospital for analysis
on each sampling day (Salzkammergut-Klinikum, Gmunden,
Austria). Red and white blood cell counts were determined
by automated counting (Siemens Advia 120, Siemens, Vienna,
Austria). Blood electrolyte concentration [potassium (K), sodium
(Na), chloride (Cl), calcium (Ca), magnesium (Mg)], blood
glucose levels (BG), indirect markers of muscular damage (CK,
LDH) and parameters of renal and liver function (CR, BUN) were
assessed by photometry and V-Lyte technology (Dimension Vista
500, Siemens, Vienna, Austria). GFR was calculated from CR
through CKD-EPI formula (chronic kidney disease epidemiology
collaboration), considering race, sex and age (Stevens and Levey,
2005; Levey et al., 2009).
The severity of acute kidney injury was classified according to
AKIN criteria published by Acute Kidney Injury Network: Stage
I (consistent with an increase in CR PRE-POST of minimum
0.3 mg/dL or 1.5 to twofold from pre-race level), stage II (increase
in post-race CR 2 to threefold from PRE) and stage III (increase
of > threefold or minimum 4 mg/dL CR with an acute increase
in CR of 0.5 mg/dL) (Mehta et al., 2007). All reference ranges
used are presented in Table 1 and are standard references with
respect to sex and ethnic group in white blood cells (WBC) and
FIGURE 1 | Race profile and refreshment stations throughout the course. Labe, refreshment station during the course.
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FIGURE 2 | Timeline of measurements. PRE, baseline measurements performed ∼7–12 h before race start; POST, post-race measurements performed within
10 min after finishing; REC, recovery measurements performed 24 h after individual finishing. Recorded parameters are given for each measurement.
TABLE 1 | Reference ranges for blood parameters.
Blood cell counts and hematocrit Blood electrolytes Parameters to indicate muscular
damage and kidney function
RBC [106 µL−1] 4.5–5.9 Na [mmol·L−1] 136–145 CK [U/L] 60–400/<1083
WBC [103 µL−1] 3.6–9.2 Cl [mmol·L−1] 98–106 LDH [U/L] 100–190
NEU [103 µL−1] 1.7–6.1 K [mmol·L−1] 3.5–5.0 CR [mg/dL] <1.5
MONO [103 µL−1] 0.18–0.62 Ca [mmol·L−1] 2.1–2.7 BUN [mg/dL] 10–20
LYM [103 µL−] 1.0–2.9 Mg [mmol·L−1] 0.7–1.0 GFR [mL/min/1.73 m2] >90
PLT [103 µL−] 143–332 BG [mg/dL] <126 mg/dL
Hct [%] 41.0–53.0
RBC, red blood cells; WBC, white blood cells; PLT, platelets; NEU, neutrophils; LYM, lymphocytes; MONO, monocytes; Hct, hematocrit; K, potassium; Na, sodium; Cl,
chloride; Ca, calcium; Mg, magnesium; CK, creatine kinase; LDH, lactate dehydrogenase; CR, serum creatinine; BUN, blood urea nitrogen; GFR, glomerular filtration rate;
BG, blood glucose. Creatine kinase: 60–400 U/L is the clinical standard reference, < 1083 U/L is for active athletes (Mougios, 2007).
platelets (PLT), and to athletic performance in CK (Brain, 1996;
Kratz et al., 2004; Mougios, 2007).
Statistics
Athletes anthropometric data (Table 2) and race performance
(Table 3) are presented as median and interquartile range (IQR),
being the most robust in outliers. Age and race performance of
study participants are given in comparison to all male finishers
of the competition. Results of all blood parameters are shown
in Table 4 as mean ± standard deviation (SD). Minimum,
maximum and number of participants out of reference range
are given in Table 5 for each parameter. Individual data are
shown in Figure 3 (blood cell count, hematocrit), 4 (blood
electrolytes and blood glucose) and 5 (muscular damage and
renal function). To analyse changes from PRE to POST and
POST to REC repeated one-way analysis of variance (ANOVA)
with post hoc analysis (Bonferroni correction) was used for
normally distributed data. Wilcoxon signed-rank test and
Friedman test were applied for data not meeting ANOVA
test requirements. Percentage differences between measurements
(PRE-POST, POST-REC, PRE-REC) were calculated to present
changes. All values were checked for clinical relevance (out of
reference, OOR; used symbols: above upper range limit, (↑);
below lower range limit, (↓); see Table 1 for reference ranges).
Due to the hot weather conditions, two participants did not
complete the race and thus 8 individuals were included in the
final analysis, yet POST and REC values were measured in
the 2 drop-outs. These data are not included in the statistics
but are shown in the graphs using different symbols. Statistics
were performed using IBM SPSS Statistics 24.0 (SPSS Inc.,
Chicago, IL, United States). A p-value below 0.05 was considered
statistically significant.
RESULTS
Characteristics and Race Performance
The race was finished between 10.4 and 16.1 h (Table 3) reflecting
large heterogeneity with regard to training and race performance.
The comparison of age and race time data between the finishers
of our study sample and all race participants indicate that
study participants represent the whole range of all participants
(Table 3). During the competition (3 am to 9 pm), the average
ambient air temperature was 20.1◦C (17◦C to 37◦C) and relative
humidity was 54% (45% to 61%), measured in the start/finish area
424 m above sea level.
Body mass did not change significantly during the race
(average weight loss: − 0.8 kg) but was slightly higher POST in
2 participants (+ 0.7 and + 0.2 kg). Race time was correlated
with athletes BMI (r = 0.862), but age, training volume and
body mass change during the race was not associated with
running performance.
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TABLE 2 | Anthropometric characteristics of participants.
N = 8
Median Min Max IQR
Age [years] 41.5 26 45 13.5
Height [cm] 180 173 191 11
Body mass [kg] PRE 74.5 67.0 90.0 15.3
POST 74.4 66.9 87.6 14.4
BMI [kg/m2] PRE 24.0 20.7 28.1 4.2
POST 23.8 20.7 28.1 4.0
Resting heart rate [bpm] 68 38 75 20.8
Training/week [h] 8.5 4 15 5.3
Data are presented as median, minimum (Min), maximum (Max), interquartile range
(IQR). Drop-outs not included.
TABLE 3 | Age and race performance of study participants compared to all male
finishers.
Study participants (N = 8) Race participants (N = 162)
Median Min Max IQR Median Min Max IQR
Age [yrs] 41.5 26 45 13.5 42.0 17 75 17.0
Race time [h] 13.33 10.37 16.05 2.92 13.58 8.82 17.47 3.55
Speed [km/h] 5.1 4.2 6.5 1.2 5.0 3.6 7.8 1.5
HR min [bpm] 95 67 110 35.5
HR avg. [bpm] 138 123 145 17.0
HR peak [bpm] 177 160 183 16.0
Lactate [mmol/L] 2.6 2.0 4.8 1.6
Data are presented as median, minimum (min), maximum (max),
interquartile range (IQR). HR min, minimal heart rate; HR avg, average heart
rate; HR peak, maximal heart rate, all during competition; lactate, post-
race lactate. 2 of 10 study participants (20%) and 55 of 210 race participants
(26%) did not finish the race; drop-outs not included.
Blood Cell Counts and Electrolytes
From PRE to POST, mean counts of total white blood cells
(WBC) (+ 137%), neutrophils (NEU) (+ 215%), monocytes
(MONO) (+ 180%) and platelets (PLT) (+ 18%) had increased
and eosinophils/basophils (EO/BASO) (− 69%) had decreased.
Red blood cells (RBC), lymphocytes (LYM), and hematocrit
(Hct) remained unchanged (Table 4). At REC, only MONO
were still increased (+ 41%) compared to PRE (Table 4).
At POST, counts of total WBC, NEU, and MONO were
OOR in all participants (↑) and in 1 person each regarding
to LYM (↓), PLT (↑), and Hct (↓) (Table 5). At REC,
Hct was OOR in 5 participants (↓), MONO in 3 (↑),
RBC (↓), total WBC (↑), and NEU (↑) in 1 person
each (Table 5).
With regard to electrolyte changes, only mean concentrations
of Ca had increased at POST (+ 13%), whereas Na, Cl, K, and Mg
remained unchanged. At POST, also BG had increased (+ 22%)
(Table 4). At REC, Ca levels were reduced (− 4%), but Mg was
elevated compared to baseline (+ 11%). Other electrolytes and
BG remained unchanged from PRE to REC (Table 4). At POST,
Ca was OOR in 7 participants (↑), Cl in 5 (↓), and Na in 3
(↓), K in 3 (↑) and Mg in 1 (↑). One day after finishing, one
runner was still OOR with regard to Na and Cl (↓), and 4 in
K (↑). 3 participants were hyperglycemic in POST, but nobody
in REC (Table 5).
Markers for Muscle Damage and Renal
Dysfunction
All mean values of markers for skeletal muscle damage (CK,
LDH) and renal dysfunction (CR, BUN, and GFR) had changed
at POST: CK (+ 1289%), LDH (+ 87%), CR (+ 72%), BUN
(+ 96%), and GFR (− 45%). At REC compared to PRE,
CK (+ 1447%), LDH (+ 56%) and BUN (+ 71%) remained
high (Table 4).
At POST, all participants were OOR with regard to LDH
(↑) and GFR (↓), 7 regarding CK (↑) considering the
specific reference for active athletes (< 1083 U/L), and
BUN (↑), respectively, and 4 regarding CR (↑). According
to the classification of the Acute Kidney Injury Network
(Mehta et al., 2007), 5 participants (63%) suffered from
AKI stage I, and 2 from stage II (25%). At REC, all
participants were OOR regarding CK and LDH (↑), and
7 regarding BUN (↑) (Table 5), 2 were still suffering
AKI stage 1. See Figures 3–5 for individual data of
every parameter.
DISCUSSION
The main findings of the present study suggest impaired
kidney function in most of the non-elite ultramarathon runners
immediately post-race, which persisted in some of them after
24 h of recovery.
The negative relationship between BMI and race performance
in ultramarathon runners is in accordance with other studies
(Hoffman, 2008). Interestingly, in the population of this study,
race performance was correlated neither with age nor training
volume, which would be expected to be the case in more elite
runners (Knechtle and Nikolaidis, 2018). This may be explained
by the fact that study participants were non-elite runners with
large interindividual performance differences.
As expected, major increases in indirect markers for potential
muscle damage (CK and LDH) have been demonstrated POST
and REC in the present study. Ultramarathon running is known
to induce muscle tissue damage followed by impaired muscle
function and release of CK and LDH into the blood (Brancaccio
et al., 2006; Baird et al., 2012; Kim et al., 2016; Knechtle
and Nikolaidis, 2018). The severity of muscle damage may be
directly linked to the distance covered and seems to be most
pronounced after mountain marathons with long downhill-
passages (eccentric load) (Brancaccio et al., 2007; Jastrzębski et al.,
2015; Kim et al., 2016; Shin et al., 2016; Knechtle and Nikolaidis,
2018). Whereas previous studies reported muscle damage to
be associated with age, fitness level and competition experience
(Noakes and Carter, 1982; Jastrzębski et al., 2016), we found
no associations. This may be explained by the small sample
size and/or the heterogeneity of our runners. On average, the
presented CK and LDH values are similar to previous findings
reported for running distances ranging from marathons to and
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TABLE 4 | Blood cell counts, serum electrolytes, tissue damage and renal function PRE, POST and REC.
After
PRE 95% CI POST 95% CI REC 95% CI p
Blood cell count, hematocrit
Erythrocytes [106 µL−1] 5.02 ± 0.38 [4.75–5.28] 5.10 ± 0.38 [4.84–5.37] 4.76 ± 0.28 [4.57–4.96] 0.002×
Leucocytes [103 µL−1] 7.07 ± 0.89 [6.45–7.68] 16.75 ± 2.60∗∗ [14.95–18.56] 7.43 ± 1.66 [6.28–8.58] <0.001×
Neutrophils [103 µL−1] 4.42 ± 0.66 [3.96–4.87] 13.90 ± 3.20∗∗ [11.68–16.11] 4.46 ± 1.52 [3.41–5.51] <0.001×
Monocytes [103 µL−1] 0.39 ± 0.04 [0.36–0.42] 1.09 ± 0.19∗∗ [0.95–1.22] 0.6 ± 0.16† [0.44–0.66] <0.001×
Eosinophils/Basophils [103 µL−1] 0.21 ± 0.12 [0.14–0.30] 0.07 ± 0.09 [0.01–0.11] 0.26 ± 0.19 [0.08–0.35] 0.034×
Lymphocytes [103 µL−1] 2.04 ± 0.52 [1.68–2.40] 1.71 ± 0.63 [1.27–2.15] 2.21 ± 0.51 [1.85–2.56] 0.057
Platelets [103 µL−1] 239.1 ± 45.63 [207.50–270.75] 282.1 ± 62.57∗∗ [238.76–325.49] 239.9 ± 48.98 [205.93–273.82] 0.008×
Hematocrit [%] 41.8 ± 1.98 [40.38–43.12] 42.0 ± 2.33 [40.39–43.61] 39.8 ± 2.25 [38.19–41.31] 0.007×
Blood electrolytes, blood glucose
Sodium [mEq·L−1] 140.13 ± 1.64 [138.99–141.26] 137.50 ± 5.42 [133.74–141.26] 139.50 ± 2.83 [137.54–141.46] 0.269
Chloride [mEq·L−1] 100.38 ± 1.69 [99.21–101.54] 95.63 ± 5.73 [91.65–99.60] 100.25 ± 3.2 [98.04–102.46] 0.027×
Potassium [mEq·L−1] 4.48 ± 0.47 [4.15–4.80] 4.89 ± 0.62 [4.45–5.32] 5.04 ± 0.71 [4.55–5.53] 0.014×
Calcium [mmol/L] 2.49 ± 0.10 [2.42–2.56] 2.80 ± 0.10∗∗ [2.73–2.87] 2.40 ± 0.07† [2.35–2.45] <0.001×
Magnesium [mmol/L] 0.78 ± 0.04 [0.76–0. 80] 0.85 ± 0.12 [0.77–0.94] 0.87 ± 0.05†† [0.83–0.90] 0.039×
Blood glucose [mg/dL] 99.75 ± 10.21 [92.68–106.82] 122.00 ± 17.55∗∗ [109.84–134.16] 99.25 ± 6.14 [95.00–103.50] 0.014×
Tissue damage marker
Creatine Kinase [U/L] 185.3 ± 138.5 [89.3–281.2] 2572.9 ± 1073.5∗ [1829.0–3316.8] 2865.4 ± 904.5† [2238.6–3492.1] 0.002×
Lactate Dehydrogenase [U/L] 200.0 ± 24.54 [182.99–217.01] 373.8 ± 48.70∗∗ [340.00–407.50] 312.2 ± 74.79† [260.34–364.00] <0.001×
Creatinine [mg/dL] 0.90 ± 0.05 [0.86–0.93] 1.54 ± 0.29∗∗ [1.34–1.74] 1.03 ± 0.14 [0.93–1.12] <0.001×
GFR [mL/min/1.73m2] 106.23 ± 7.77 [100.85–111.61] 58.53 ± 14.33∗∗ [48.60–68.46] 93.23 ± 13.06 [84.18–102.28] <0.001×
Blood urea nitrogen [mg/dL] 14.88 ± 4.55 [11.72–18.03] 29.13 ± 6.81∗∗ [24.40–33.85] 25.50 ± 4.44†† [22.42–28.58] <0.001×
Values are shown as means ± SD and p-values of ANOVAs and post hoc tests. Drop-outs are not included in statistics. See Figures 3–5 for single parameters. GFR,
Glomerular filtration rate; p, adjusted p-value of ANOVA; 95% CI, 95% confidence interval. ×Significance by ANOVA (p < 0.05); ∗PRE-POST, p < 0.05; ∗∗PRE-POST,
p < 0.01; †PRE-REC, p < 0.05; ††PRE-REC, p < 0.01.
ultramarathons up to 100 km (Kim et al., 2007; Jastrzębski et al.,
2015; Shin et al., 2016).
Although CK may be considered as an indirect marker
for muscle damage in athletes, a large variability of CK
concentrations post-exercise has been reported (Brancaccio
et al., 2007; Kim and Lee, 2015). This may be explained by
the dependence of serum CK increase on body composition
(muscle mass), metabolic dysfunctions (depletion of nutrients
during excessive exercise), inflammatory effects due to immune
responses to exercise, electrolyte and hydration disturbances
(hypocalcemia, hyper-/hyponatremia, hyper/hypokalemia)
which is greatly influenced by ambient temperature (thermal
stress) (Brancaccio et al., 2006; Baird et al., 2012; Kim and
Lee, 2015; Kim et al., 2016). Moreover, the heterogeneity of
serum enzyme levels depends on genetic disposition (low-
vs. high-responder) (Brancaccio et al., 2007). Although
the CK level in serum is an indirect marker for clinically
relevant muscle injury, regular participation in high-volume
exercise consistently results in increased serum CK levels,
suggesting that CK leakage to the blood is a physiological
response to prolonged exercise (Mougios, 2007; Baird et al.,
2012). Usually, even distinct elevations of serum enzymes
after prolonged and intense exercise do not indicate serious
muscle damage because CK and LDH levels regularly return
to baseline within some days without medical treatment
(Baird et al., 2012). Thus, increased serum CK alone is not an
accurate reflection of structural muscle damage and may be a
consequence of normal muscular activity (Baird et al., 2012).
Rhabdomyolysis, a serious syndrome of muscle injury, is
usually associated with CK levels between 10,000–200,000
U/L (Huerta-Alardin et al., 2005; Baird et al., 2012; Kim
and Lee, 2015). Although we did not determine additional
indicators of potential rhabdomyolysis, such as myoglobin,
CK concentrations of our participants do not indicate serious
damage of muscle tissue.
Two effects are known to cause leucocytosis during workload:
a demargination of WBC into the blood stream (1) and
inflammation following tissue injury, where the increase is
characterized primarily by NEU and MONO, but not by LYM
(2) (Wells et al., 1982; Nieman et al., 1989; Scharhag et al., 2002;
Suzuki et al., 2003). Even small exercise-related muscle damage
contributes to local and systemic inflammation, depending on
age, exercise volume and intensity, and eccentric contribution
(Gabriel and Kindermann, 1997; Scharhag et al., 2002; Peake
et al., 2005). WBC concentrations measured after various
ultramarathons be by are to be 9.4 ∗ 103 µL−1 after 100 km
non-stop running (Jastrzębski et al., 2016) or 13.3 ∗ 103 µL−1
after 24 h non-stop running with a mean covered distance of
140.3 km (Passaglia et al., 2013). WBC values in the present
study are even higher despite shorter race distance and times.
Thus, the linearity between stress on the immune system and
skeletal muscle damage suggest that our runners suffer from
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TABLE 5 | Minimum, maximum and number of participants out of medical reference PRE, POST, REC of blood cell counts, serum electrolytes, and tissue damage
and renal function.
Min/Max OOR (N = 8)
PRE POST REC PRE POST REC
Blood cell count
Erythrocytes [106 µL−1] 4.60/5.57 4.58/5.71 4.23/5.19 – – 1 ↓
Leucocytes [103 µL−1] 5.85/8.68 13.46/21.01 4.79/10.16 – 8 ↑ 1 ↑
Neutrophils [103 µL−1] 3.24/5.27 9.42/18.75 2.15/6.54 – 8 ↑ 1 ↑
Monocytes [103 µL−1] 0.33/0.48 0.86/1.38 0.27/0.76 – 8 ↑ 3 ↑
Eosinophils/Basophils [103 µL−1] 0.05/0.39 0.02/0.22 0.08/0.54 n/s n/s n/s
Lymphocytes [103 µL−1] 1.37/2.80 0.68/2.64 1.34/2.90 – 1 ↓ –
Platelets [103 µL−1] 177/305 206/416 186/319 – 1 ↑ –
Hematocrit [%] 39/45 38/45 36/43 2 ↓ 1 ↓ 5 ↓
Blood electrolytes, blood glucose
Sodium [mEq·L−1] 138/142 129/145 135/144 – 3 ↓ 1 ↓
Chloride [mEq·L−1] 97/102 87/105 97/105 1 ↓ 5 ↓ 1 ↓
Potassium [mEq·L−1] 3.90/5.50 4.30/6.20 4.00/6.20 1 ↑ 3 ↑ 4 ↑
Calcium [mEq·L−1] 2.30/2.62 2.63/2.94 2.25/2.47 – 7 ↑ –
Magnesium [mEq·L−1] 0.74/0.84 0.69/1.05 0.81/0.94 – 1 ↑ –
Blood glucose [mg/dL] 86/112 95/157 89/107 – 3 ↑ –
Muscular damage, renal function
Creatine Kinase [U/L] 74/459 1022/4810 1300/4139 – 7 ↑ 8 ↑
Lactate Dehydrogenase [U/L] 167/240 321/444 192/411 5 ↑ 8 ↑ 8 ↑
Creatinine [mg/dL] 0.84/0.97 1.15/2.07 0.89/1.26 – 4 ↑ –
GFR [mL/min/1.73m2] 93.89/116.92 40.0/87.34 71.87/107.7 – 8 ↓ 2 ↓
Blood urea nitrogen [mg/dL] 10.0/23.0 20.0/39.0 20.0/32.0 1 ↑ 7 ↑ 7 ↑
Values are shown as minimum (Min), maximum (Max). Drop-outs not shown. OOR, out of reference range; GFR, glomerular filtration rate. ↑, above upper range limit; ↓,
below lower range limit. See Figures 3–5 for single parameters.
higher muscle damage than similar studies, presumably caused
by running downhill passages and heat (Knechtle and Nikolaidis,
2018). However, according to our study, levels of WBC and
NEU commonly decrease within 24–48 h after ultramarathon,
indicating a normal physiologic process after intensive workload
rather than serious damage (Nieman et al., 1989; Scharhag et al.,
2002). Increased MONO at REC may indicate inflammation
(Nieman et al., 1989).
Kidney dysfunction and AKI are common after excessive
exercise indicated by serum CR elevation and eGFR decrease
(Hou et al., 2015; Hodgson et al., 2017). This is a consequence
of two processes, (1) the physiologic redistribution of blood
flow from the kidney to skeletal muscle during exercise
and/or (2) the direct toxic effect of released potassium and
myoglobin following severe muscular damage (Baird et al.,
2012; Hodgson et al., 2017). In ultramarathon studies, about
30–85% of the participants met AKI criteria immediately after
competition where most of them were AKI stage 1, which is
usually not considered to be of clinical relevance (Hou et al.,
2015; Hodgson et al., 2017). Renal dysfunction and serum
CR were shown mostly to return to baseline within 24–48 h
(Hodgson et al., 2017).
A relatively large percentage of participants in the present
study suffered AKI (25% AKI stage II), likely due to only
moderate competition experience, thermal stress and the course
containing a large part of downhill running (eccentric exercise).
Exercise-associated hyponatremia EAH (3 OOR POST) seems
not to be an important risk factor in the present study.
However, the fact that 25% of our participants still showed
AKI stage I at REC and BUN being OOR in 7 runners
(88%) at REC may indicate sustained renal dysfunction.
Usually, runners with mild AKI do not require medical
attention locally, but a review of case reports summarizes
that the majority of runners with AKI post-race (21 of 27,
77%) requested medical attention during the consequent days
(Hodgson et al., 2017).
Main limitations to be mentioned are the small sample
size, the inclusion of only male participants and the lack of
monitoring food and fluid intake exactly during the competition
and the 24 h of recovery. However, the broad range of
blood parameters determined in this heterogenous sample
of mainly recreational runners and the fact that REC has
been rarely investigated in ultramarathon running, may be
considered as strength.
In conclusion, changes in CK and LDH levels and
leucocytosis may likely represent relatively harmless “side-
effects” of prolonged running in individuals with only moderate
ultramarathon experience and training status. However, AKI
may become clinically relevant in this population under the
given conditions, which should be considered by responsible
race managers and medical advisors. Coaches and athletes must
be aware of the kidney injury risk related to ultramarathon
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FIGURE 3 | Individual data on blood cell counts and hematocrit before competition (PRE), immediately after the race (POST) and 24 h after finishing (REC). Changes
of leucocytes (A), platelets (B), erythrocytes (C), hematocrit (D), neutrophils (E), lymphocytes (F), and monocytes (G). Drop-outs marked triangular. ∗p < 0.05,
∗∗p < 0.01.
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FIGURE 4 | Individual data on blood electrolytes and blood glucose before competition (PRE), immediately after the race (POST) and 24 h after finishing (REC).
Changes of potassium (A), sodium (B), chloride (C), calcium (D), magnesium (E), and blood glucose (F). Drop-outs marked triangular. ∗p < 0.05, ∗∗p < 0.01.
running and predisposing risk factors such as individual
training status and competition experience, age, running
distance, route profile, and ambient temperature. Gradual
adaptation to such conditions and medical surveillance are most
important preventive measures. Future research should focus
on the impairment and recovery of post-race kidney function
over prolonged periods, i.e., days to weeks, and associated
individual risk factors.
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FIGURE 5 | Individual data on markers of muscular damage and renal function before competition (PRE), immediately after the race (POST) and 24 h after finishing
(REC). Changes of creatine kinase (A), lactate dehydrogenase (B), creatinine (C), glomerular filtration rate (D), and blood urea nitrogen (E). Drop-outs marked
triangular. ∗p < 0.05, ∗∗p < 0.01.
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